AegisAI, founded by former Google security executives, has raised $36 million to combat AI-generated spear phishing attacks. The company deploys AI agents that analyze incoming messages in real-time, looking for subtle anomalies that traditional rule-based security systems miss. The funding validates growing market concern about increasingly sophisticated attacks enabled by generative AI, where automated systems can craft convincing impersonation attempts at scale.
AI is transforming pharmaceutical research by dramatically reducing the time and cost required to design and develop new medicines. Machine learning models can predict molecular properties and identify promising drug candidates far faster than traditional trial-and-error methods, addressing a critical bottleneck in biologic medicine development. Researchers are using AI to screen massive chemical spaces and identify viable therapeutic candidates that might take years to discover through conventional approaches.
AMD has announced Helios, a new rack-scale AI system designed to compete directly with Nvidia's dominant position in AI infrastructure. The system is slated to begin shipping to customers later this year. AMD's Helios represents a significant push into the hardware layer that powers large-scale AI deployments, offering enterprises an alternative to Nvidia's GPU-centric architecture for training and inference workloads.
Anthropic has rolled out voice mode for Claude Opus and Sonnet, its more capable models, expanding beyond the faster but less powerful Haiku variant that previously had exclusive voice access. The update brings conversational AI capabilities to enterprise applications including Gmail, Slack, and Canva, enabling users to interact with Claude's most advanced reasoning abilities through natural spoken language. This represents a significant shift in how businesses can deploy AI-assisted work—voice-based workflows are now available with the company's most capable reasoning engine.
NTT DATA Group, a major IT services firm, has deployed ChatGPT Enterprise and OpenAI's Codex to automate incident analysis and knowledge work across 9,000 employees. The company reduced incident response analysis time from hours to 30 minutes—a significant operational improvement. The deployment demonstrates how large organizations are using AI to amplify the speed of technical teams without replacing them, enabling faster problem resolution across the entire workforce.
OpenAI has made Health in ChatGPT available to all eligible U.S. users, allowing them to securely connect medical records and Apple Health data directly to the chatbot. The feature enables ChatGPT to provide personalized health insights based on a user's actual health history and biometric data. OpenAI emphasized security and compliance throughout the rollout, positioning this as a way to help individuals better understand their health trends and patterns with AI assistance.
OpenAI has unveiled Presence, an enterprise-grade agent platform designed to automate customer-facing and internal workflows using voice and chat interfaces. The platform is positioned as a proven solution for organizations looking to deploy trusted AI agents that can handle real business processes. Presence combines OpenAI's LLM capabilities with enterprise security and integration features needed for production deployments.
Patreon has announced a 20% workforce reduction, affecting approximately 93 employees. CEO Jack Conte stated the layoffs are driven by AI fundamentally transforming the technology landscape, though he emphasized the company doesn't view AI as simply replacing human workers. The reduction suggests Patreon is optimizing its operational structure in response to AI's impact on how the company delivers services and manages its platform.
The Trump administration is actively debating how to respond to the growing sophistication of Chinese AI models and capabilities. The discussion involves weighing technology export controls, competitive investment priorities, and national security concerns as Chinese AI systems become increasingly capable. This internal policy debate will likely shape how the U.S. approaches AI regulation, export controls, and strategic investment over the coming months.